These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Methods of detoxification and their role in treating patients with opioid dependence. O'Connor PG JAMA; 2005 Aug; 294(8):961-3. PubMed ID: 16118388 [No Abstract] [Full Text] [Related]
27. [A review of naltrexone maintenance programs: effectiveness, predictors and profile]. Madoz-Gúrpide A; Ochoa E; Baca-García E Med Clin (Barc); 2002 Sep; 119(9):351-5. PubMed ID: 12356367 [No Abstract] [Full Text] [Related]
28. First, do no harm: naltrexone-accelerated detoxification. Gaughwin MD Med J Aust; 1999 Nov; 171(9):499. PubMed ID: 10615346 [No Abstract] [Full Text] [Related]
29. Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD). Albanese AP; Gevirtz C; Oppenheim B; Field JM; Abels I; Eustace JC J Addict Dis; 2000; 19(2):11-28. PubMed ID: 10809517 [TBL] [Abstract][Full Text] [Related]
30. Naltrexone: a review of existing sustained drug delivery systems and emerging nano-based systems. Goonoo N; Bhaw-Luximon A; Ujoodha R; Jhugroo A; Hulse GK; Jhurry D J Control Release; 2014 Jun; 183():154-66. PubMed ID: 24704710 [TBL] [Abstract][Full Text] [Related]
31. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction. Simon DL Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434 [No Abstract] [Full Text] [Related]
32. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Fishman MJ; Winstanley EL; Curran E; Garrett S; Subramaniam G Addiction; 2010 Sep; 105(9):1669-76. PubMed ID: 20626723 [TBL] [Abstract][Full Text] [Related]
33. Sexual dysfunction among male patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence. Ramdurg S; Ambekar A; Lal R J Sex Med; 2012 Dec; 9(12):3198-204. PubMed ID: 21366875 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence. Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678 [TBL] [Abstract][Full Text] [Related]
38. Strategies to maximize the efficacy of naltrexone for alcohol dependence. O'Malley SS NIDA Res Monogr; 1995; 150():53-64. PubMed ID: 8742772 [No Abstract] [Full Text] [Related]
39. Gender differences in treatment and clinical characteristics among patients receiving extended release naltrexone. Herbeck DM; Jeter KE; Cousins SJ; Abdelmaksoud R; Crèvecoeur-MacPhail D J Addict Dis; 2016; 35(4):305-314. PubMed ID: 27192330 [TBL] [Abstract][Full Text] [Related]